UBS analyst AJ Rice reiterated a Buy rating and $288.00 price target on Tenet Healthcare (NYSE: THC).The analyst commented, "Tenet ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments